(12-249) Time of Sustained Complete Remission upon the Discontinuation of a Bruton Tyrosine Kinase Inhibitor in Patients with Chronic Lymphocytic Leukemia

Wednesday, December 7, 2022

2:00 PM – 3:00 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Oncology/Hematology

Co-Author(s): Jessica Knechel, Jasen Knudsen

Primary Author(s)

Jasmine E. Nguyen, PharmD
Pharmacy Resident
Kaiser Permanente Northwest, Washington